Practical Dimensions And Optimal Deployment Of Non-VKA Oral Anticoagulants In NVAF: The Role of Key Clinical Factors – Age, CHADS2-VASc2 Score, Renal Function, Bleeding Risk, Previous Stroke, Dosing and Adherence – In Selecting an Evidence-Based Approach to Stroke Prevention in AF - Christian T. Ruff, MD, MPH

Practical Dimensions And Optimal Deployment Of Non-VKA Oral Anticoagulants In NVAF : The Role of Key Clinical Factors – Age, CHADS2-VASc2 Score, Renal Function, Bleeding Risk, Previous Stroke, Dosing and Adherence – In Selecting an Evidence-Based Approach to Stroke Prevention in AF - Christian T. Ruff, MD, MPH


Published

November 22, 2016

Created by

CMEducation Resources symposium